mBio
Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition.
Erin Yuan, Chelsea L Hansen, Sana Tamim, Samia Kanwar, David J Spiro, Refugio Gonzalez-Losa, Laura Conde-Ferraez, Pilar Granja-Pérez, Salha Villanueva-Jorge, Irma López-Martínez, Gisela Barrea-Badillo, André Corvelo, Samantha Fennessey, Michael C Zody, Guadalupe Ayora-Talavera
Published: 202610.1128/mbio.02432-25
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines reduced severe coronavirus disease 2019, but variants like Delta and Omicron caused widespread breakthrough infections (BIs). Mexico, offering diverse vaccines, and its Yucatán reg…
Preview only. Read the full abstract at the source